Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results

Go back to Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results
GALMED PHARMACEUTIC (NASDAQ: GLMD) Delayed: 0.60 --0 (-0%)
Previous Close $0.60    52 Week High $9.70 
Open $0.57    52 Week Low $2.78 
Day High $0.60    P/E N/A 
Day Low $0.57    EPS $0.00 
Volume 21,975